Painless liver check: could a quick scan replace the needle?

NCT ID NCT02897908

Recruiting now Knowledge-focused Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses a device called FibroScan to measure liver stiffness and fat content in people with liver disease. The scan is non-invasive, like an ultrasound, and takes only a few minutes. Researchers aim to build a large database of these measurements to help improve future diagnosis and monitoring of liver conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: vibration controlled transient elastography (FibroScan)
What this could lead to: If successful, this database could help researchers develop better ways to diagnose and monitor liver disease without needing a biopsy.
What could go wrong: This is an observational study that does not test a treatment, so it will not directly improve patient outcomes. The database's usefulness depends on future research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISEASE OF LIVER AND BILE DUCT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Digestive System Diseases hepatitis C virus infection hepatobiliary disorder metabolic dysfunction-associated steatohepatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DISEASE OF LIVER AND BILE DUCT

Contacts and locations

Locations

Conventus Medical Office Building
RECRUITING

Buffalo, New York, 14203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.